News

Elsevier has launched SciVal Funding, a comprehensive funding intelligence solution for US research institutions. The platform helps researchers locate the most appropriate grant opportunities in order to maximise

Afinitor (everolimus) has been licensed for the treatment of advanced kidney cancer after failure of treatments which prevent the growth of the tumour’s blood vessels. The growth of

Inspirion Delivery Technologies (IDT) has announced that last week the company completed a pre-investigational new drug (Pre-IND) meeting with the FDA to determine the clinical and regulatory pathway

Wyeth Pharmaceuticals has announced that the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the company’s pneumococcal conjugate

Nutricia North America has contacted customers to undertake the voluntary recall and replacement of one lot of the specialised infant formula product, Neocate. This recall involves a limited

Addex Pharmaceuticals has completed the enrollment in the phase IIb trial of ADX10059 as a monotherapy in patients with gastroesophageal reflux disease (GERD). ADX10059 is a first-in-class reflux

Onyx Pharmaceuticals has begun enrolling patients in a phase 1 study of ONX 0801, a novel alpha-folate receptor-mediated thymidylate synthase (TS) inhibitor, as a potential treatment for advanced

Merck & Co has entered into an exclusive agreement with CSL Biotherapies, a subsidiary of CSL Limited, to market and distribute CSL’s seasonal influenza vaccine Afluria in the

Raptor Pharmaceuticals Corp has revealed that its stockholders have approved the proposals to complete the proposed merger with TorreyPines Therapeutics. According to the company, the merger is expected